Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children
Nebulized Dexmedetomidine to Reduce Post-Anesthesia Delirium of Sevoflurane in Preschool Children Undergoing Elective Surgery
1 other identifier
interventional
72
1 country
1
Brief Summary
Analyzing the effectiveness of nebulized dexmedetomidine 2 mcg/kg in reducing the incidence of post-anesthesia delirium in preschool children undergoing elective surgery with sevoflurane inhalation general anesthesia. Researchers will compare nebulized Dexmedetomidine to a placebo (a look-alike substance that contains no drug) to see if the drug can reduce post anesthesia delirium incidence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Dec 2024
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 13, 2024
CompletedFirst Submitted
Initial submission to the registry
December 29, 2024
CompletedFirst Posted
Study publicly available on registry
January 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2025
CompletedJanuary 22, 2025
December 1, 2024
2 months
December 29, 2024
January 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
reduce post anesthesia delirium incidence
After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the PAED score at 15, 30, 60, and 120 minutes post-surgery in the recovery room.
120 minutes (after extubation till discharge from recovery room)
Study Arms (2)
Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children
ACTIVE COMPARATORNebulization with the anesthetic drug dexmedetomidine at a dose of 2 mcg/kg body weight, diluted to 3 ml with 0.9% normal saline, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the pediatric anesthesia emergence delirium score (PAED score) at 15, 30, 60, and 120 minutes post-surgery in the recovery room.
Nebulized Normal Saline 0.9% for Post-Anesthesia Delirium in Preschool Children
PLACEBO COMPARATORNebulization with normal saline 0.9% 3ml, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the pediatric anesthesia emergence delirium score (PAED score) at 15, 30, 60, and 120 minutes post-surgery in the recovery room.
Interventions
Nebulization with the anesthetic drug dexmedetomidine at a dose of 2 mcg/kg body weight, diluted to 3 ml with 0.9% normal saline, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the PAED score at 15, 30, 60, and 120 minutes post-surgery in the recovery room
Nebulization with normal saline 0.9% 3 ml, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the PAED score at 15, 30, 60, and 120 minutes post-surgery in the recovery room
Eligibility Criteria
You may qualify if:
- Pediatric patients aged 2 to 6 years old.
- Planned general anesthesia using inhalation sevoflurane with endotracheal tube techniques
- Parents agree to participate in the study
You may not qualify if:
- Pediatric patients with \> ASA II.
- Difficult airway management.
- Emergency surgery.
- Congenital abnormalities of vital organs.
- Malnutrition
- history or diagnosed with mental or cognitive disorders.
- History of upper respiratory infection within 2 weeks before the procedure.
- History of allergy to dexmedetomidine.
- Surgery duration estimation exceeding 180 minutes.
- Parents refuse to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anesthesiology and Intensive Therapy Udayana University
Denpasar, Bali, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
December 29, 2024
First Posted
January 7, 2025
Study Start
December 13, 2024
Primary Completion
February 7, 2025
Study Completion
February 13, 2025
Last Updated
January 22, 2025
Record last verified: 2024-12